Fibrotic NSIP
1. Challenge
59-year-old male presents with
history of scleroderma,
Raynaud’s disease, and
ILD

2. Findings
Bibasilar traction bronchiectasis Traction bronchiectasis
Subpleural sparing
Volume loss with mild shrinkage of lower lobes with posterior
Air-fluid level in esophagus

59-year-old male presents with history of scleroderma, Raynaud’s disease, and ILD
Upper Image
Axial CT shows bronchiectasis, and bronchiolectasis with crowding of the bronchovascular bundles posteriorly (green arrowheads) with volume loss (note fissural displacement -pink arrowheads). There is subpleural sparing posteriorly (blue arrowheads) Minor changes of peripheral reticular changes (black arrowheads), and minimal ground glass changes are present. An air-fluid level is present in the distended esophagus indicating reflux (yellow arrowhead).
The lower image focuses on the traction bronchiectasis caused by the fibrotic process
Ashley Davidoff MD TheCommonVein.net 110Lu 136598cL
Radiologic Findings
| Finding | Description |
|---|---|
| Bibasilar bronchiectasis | Dilated bronchi most pronounced in the lower lobes |
| Traction bronchiectasis | Bronchi pulled apart due to fibrotic lung retraction |
| Reticulation | Fine interstitial lines, especially subpleural and basal |
| Subpleural sparing | The lung tissue immediately adjacent to the pleura is relatively spared from disease, a characteristic feature of NSIP. |
| Volume loss | Mild shrinkage of lower lobes with posterior displacement of fissures |
| Architectural distortion | Abnormal lung anatomy due to chronic fibrosis |
| Air-fluid level in esophagus | Suggests esophageal dysmotility — common in scleroderma |
Distinguishing Fibrotic from Cellular NSIP
This case is classified as fibrotic NSIP due to the predominance of features indicating scarring and architectural distortion over inflammatory changes. The table below outlines the key distinctions:
| Feature | Distinguishing Characteristic in Fibrotic vs. Cellular NSIP |
|---|---|
| Reticulation and Traction Bronchiectasis | – Predominant in Fibrotic NSIP: These findings are the hallmark of fibrosis, representing irreversible scarring and distortion of the airways. This case shows significant traction bronchiectasis. – Minimal or Absent in Cellular NSIP: The primary finding is inflammation, not established fibrosis. |
| Ground-Glass Opacity (GGO) | – Minimal in Fibrotic NSIP: While some GGO can be present, it is not the dominant feature. In this case, GGO is minimal. – Dominant in Cellular NSIP: Extensive GGO is the characteristic finding, representing active interstitial inflammation. |
| Volume Loss and Architectural Distortion | – Prominent in Fibrotic NSIP: Fibrosis leads to lung shrinkage and displacement of structures like fissures, which is evident in this case. – Mild or Absent in Cellular NSIP: The lung architecture is generally preserved because significant scarring has not occurred. |
| Expansion of Spared Lobules | – A Feature of Fibrotic NSIP: In this case, the intense fibrotic traction centrally causes a compensatory expansion of the less affected, spared secondary lobules in the subpleural regions. This distortion highlights the severity of the fibrotic pull. |
Anatomical Basis for Radiologic Patterns in NSIP
| Imaging Feature | Underlying Explanation |
| Basal predominance | – Gravity-dependent circulation leads to higher perfusion and lymphatic drainage in lower lobes.- Inflammation and fibrosis may be amplified in these regions, especially in CTDs like scleroderma. |
| Subpleural sparing | – The subpleural lung is less vascularized and more resistant to fibrosis.- In NSIP, inflammation tends to spare these terminal acinar regions, in contrast to UIP where damage begins subpleurally. |
| Bronchovascular distribution | – The interstitium surrounding bronchi and vessels is a primary target for inflammation in NSIP.- Fibrosis follows peribronchovascular connective tissue sheaths, leading to traction bronchiectasis in these regions. |
Other Images from this Case (110Lu)

59-year-old male presents with history of scleroderma, Raynaud’s disease, and ILD
CXR shows basilar reticular changes and low lung volumes. There is an air bronchogram in the left lower lobe as a result of traction bronchiectasis and fibrotic change surrounding the bronchovascular bundle
The CT highlights the bronchovascular thickening, and bronchiectasis that results in the air bronchogram. In addition there is volume loss, and subpleural sparing. The fibrotic process has resulted in traction of the secondary lobules in the region of subpleural sparing
Ashley Davidoff MD TheCommonVein.net 110Lu 136592c
3. Diagnosis
Table 1. Clinical Definition and Context: Fibrotic NSIP
| Category | Details |
|---|---|
| What is it | Fibrotic NSIP is a chronic interstitial lung disease characterized by uniform fibrosis and inflammation of the alveolar walls, most often seen in connective tissue disease (CTD) such as scleroderma. |
| Caused by | Most commonly associated with autoimmune disorders, particularly systemic sclerosis (scleroderma), polymyositis/dermatomyositis, and mixed CTD. May also be idiopathic. |
| Resulting in | Progressive fibrosis of the interstitium, leading to volume loss, impaired gas exchange, and restrictive lung disease. |
| Structural changes | Reticulation, traction bronchiectasis, subpleural sparing, and loss of normal alveolar architecture. |
| Functional changes | Reduced lung compliance, restrictive pattern on PFTs, and decreased DLCO. May lead to hypoxia and decreased exercise tolerance. |
| Diagnosis | – Clinical: Progressive dyspnea, cough, CTD symptoms (Raynaud’s, GERD, joint stiffness). – Imaging: High-resolution CT shows bibasilar fibrosis, subpleural sparing, and traction bronchiectasis. – Histology (if needed): Homogeneous fibrosis without temporal heterogeneity. – Other: Positive serologies (ANA, Scl-70) may support underlying CTD. |
| Complications | Pulmonary hypertension, chronic respiratory insufficiency, secondary infection, progression to end-stage lung disease. |
| Treatment | Immunosuppressive therapy (e.g., mycophenolate mofetil, cyclophosphamide), antifibrotics (e.g., nintedanib), oxygen therapy, pulmonary rehab, and monitoring for CTD progression. |
4. Medical History and Culture
1. Etymology and Language
| Concept | Explanation |
|---|---|
| Pneumonia | From Greek pneumon (lung) + -ia (condition) — historically referred to any condition involving the lung, not just infection. In modern usage, it is most often associated with infectious inflammation. In NSIP, “pneumonia” refers to non-infectious inflammation of the interstitium. |
| Interstitial | Latin interstitium, meaning “the space between” — refers to the lung’s connective tissue scaffolding |
| Fibrosis | From Latin fibra (fiber) — abnormal accumulation of fibrous tissue in the lung |
| Sclerosis | Greek skleros (hard) — reflects the stiffening associated with systemic sclerosis |
2. Historical and Cultural Associations
| Theme | Connection |
| Fibrosis and Time | Fibrosis is a disease of accumulation and delay — it evolves slowly, often unnoticed |
| Scleroderma in Art | Rarely depicted explicitly in classical art, but tight skin and stiffness echo through symbolic representation of rigidity |
| Lung Disease in Literature | In La Traviata (Verdi), Violetta’s struggle with consumption mirrors themes of invisible, progressive decay — resonant with fibrotic ILDs |
| The Invisible Enemy | Fibrotic NSIP reflects a broader metaphor — of diseases that silently shape and deform structure without immediate destruction |
| History of NSIP | NSIP was first formally described as a distinct histopathologic pattern by Katzenstein and Fiorelli in 1994, emphasizing its more uniform and less destructive features compared to UIP. |
4. Artistic Parallels and Diagnostic Philosophy
| Domain | Parallel |
| Visual arts | Impressionist works like Monet’s fog series parallel the subtlety of NSIP’s radiologic signs — diffuse, layered, not sharply defined |
| Poetry | Emily Dickinson’s introspective poetry on breath and silence (“I felt a Funeral, in my Brain”) captures the stillness of ILD |
| Philosophy | Heidegger’s concept of Being-toward-death — slowly progressive conditions invite existential awareness |
| Radiologic insight | Diagnosing fibrotic NSIP requires attunement to subtlety — noticing what is less, not just what is more |
6. MCQs
Part A — Questions
| Question | Choices |
|---|---|
| Q1. In systemic sclerosis–associated ILD presenting with fibrotic NSIP, which pathobiologic process most directly drives uniform interstitial fibrosis with traction on secondary pulmonary lobules? |
|
| Q2. Which histologic combination best distinguishes fibrotic NSIP from UIP in this clinical context? |
|
| Q3. For a 59-year-old man with scleroderma-associated fibrotic NSIP and declining FVC, which disease-modifying therapy has the strongest evidence for first-line use to stabilize lung function while balancing tolerability? |
|
| Q4. Which pulmonary function profile most closely matches fibrotic NSIP with basal volume loss and traction bronchiectasis? |
|
| Q5. On the coronal CT described (bibasilar volume loss, reticulation, ground-glass change, bronchovascular thickening, traction bronchiectasis), which single feature most strongly favors fibrotic NSIP over UIP? |
|
| Q6. Which coronal CT constellation best differentiates fibrotic NSIP from UIP/IPF in systemic sclerosis? |
|
| Q7. An ancillary thoracic CT finding that supports systemic sclerosis in this case and may exacerbate ILD by micro-aspiration is: |
|
Q1. In systemic sclerosis–associated ILD presenting with fibrotic NSIP, which pathobiologic process most directly drives uniform interstitial fibrosis with traction on secondary pulmonary lobules? |
||
| A) Episodic mucus plugging with distal resorptive collapse | ✗ Incorrect | • Obstructive/resorptive mechanism; not uniform fibrotic traction |
| B) Acute diffuse alveolar damage with hyaline membranes | ✗ Incorrect | • DAD pattern (acute); not typical of chronic fibrotic NSIP |
| C) Autoimmune endothelial injury with TGF-β/PDGF-mediated myofibroblast activation and ECM cross-linking | ✓ Correct | • SSc vasculopathy → profibrotic signaling → myofibroblast contraction • Cross-linked collagen transmits traction to lobular septa • Varga, Nat Rev Rheumatol 2014 |
| D) Passive compression by large chronic pleural effusions | ✗ Incorrect | • Compressive atelectasis; reversible, not intrinsic fibrosis |
Q2. Which histologic combination best distinguishes fibrotic NSIP from UIP in this clinical context? |
||
| A) Patchy subpleural honeycombing with numerous fibroblastic foci | ✗ Incorrect | • Classic for UIP/IPF, not NSIP |
| B) Organizing pneumonia with intra-alveolar buds (Masson bodies) | ✗ Incorrect | • Represents OP; may coexist but not defining NSIP fibrosis |
| C) Necrotizing granulomas with caseation | ✗ Incorrect | • Granulomatous infection/HP differential, not NSIP |
| D) Temporally uniform interstitial fibrosis ± low-grade inflammation; relative architectural preservation; scant fibroblastic foci | ✓ Correct | • Temporal uniformity is the hallmark of NSIP • Less honeycombing than UIP • Travis, Am J Respir Crit Care Med 2008 |
Q3. For a 59-year-old man with scleroderma-associated fibrotic NSIP and declining FVC, which disease-modifying therapy has the strongest evidence for first-line use to stabilize lung function while balancing tolerability? |
||
| A) Long-term high-dose oral corticosteroids alone | ✗ Incorrect | • Limited efficacy; safety concerns in SSc (renal crisis risk) |
| B) Mycophenolate mofetil | ✓ Correct | • Similar efficacy to cyclophosphamide with better tolerability • Standard first-line in SSc-ILD • Tashkin, Ann Intern Med 2016 (Scleroderma Lung Study II) |
| C) Short-acting bronchodilators as monotherapy | ✗ Incorrect | • Symptomatic only; no disease modification |
| D) Montelukast | ✗ Incorrect | • Not disease-modifying in SSc-ILD |
Q4. Which pulmonary function profile most closely matches fibrotic NSIP with basal volume loss and traction bronchiectasis? |
||
| A) Restriction with reduced FVC/TLC and reduced DLCO; near-normal or high FEV1/FVC | ✓ Correct | • Volume loss from fibrosis → restriction • Gas-exchange impairment lowers DLCO • ATS/ERS Interpretative Strategies, Eur Respir J 2005 |
| B) Normal lung volumes with isolated DLCO reduction only | ✗ Incorrect | • Possible early disease, but not typical once fibrotic traction present |
| C) Obstruction with large bronchodilator reversibility and high FeNO | ✗ Incorrect | • Asthma pattern, not fibrotic NSIP |
| D) Marked hyperinflation with increased TLC and RV/TLC | ✗ Incorrect | • Emphysema/air-trapping profile |
Q5. On the coronal CT described (bibasilar volume loss, reticulation, ground-glass change, bronchovascular thickening, traction bronchiectasis), which single feature most strongly favors fibrotic NSIP over UIP? |
||
| A) Basal predominance | ✗ Incorrect | • Seen in both NSIP and UIP |
| B) Traction bronchiectasis | ✗ Incorrect | • Non-specific; present in many fibrosing ILDs |
| C) Subpleural sparing adjacent to fibrotic change | ✓ Correct | • Key discriminator for NSIP vs UIP • Fits the case caption’s distribution • Fleischner Glossary, Radiology 2008; Kim, AJR 2008 |
| D) Reticulation | ✗ Incorrect | • Non-specific fibrotic sign |
Q6. Which coronal CT constellation best differentiates fibrotic NSIP from UIP/IPF in systemic sclerosis? |
||
| A) Peripheral, coarse honeycombing with marked subpleural predominance and minimal ground glass | ✗ Incorrect | • Typical of UIP/IPF |
| B) Symmetric basal reticulation and ground glass with traction bronchiectasis and relative subpleural sparing | ✓ Correct | • Canonical NSIP pattern in SSc-ILD • Honeycombing uncommon/limited • Goh, Thorax 2008 |
| C) Random centrilobular nodules with mosaic attenuation only on expiration | ✗ Incorrect | • Small-airways disease/HP pattern |
| D) Lobar collapse from central mucus plug with rapid re-expansion after suctioning | ✗ Incorrect | • Obstructive/resorptive atelectasis |
Q7. An ancillary thoracic CT finding that supports systemic sclerosis in this case and may exacerbate ILD by micro-aspiration is: |
||
| A) Cavitary upper-lobe consolidation with air-fluid level | ✗ Incorrect | • Suggests necrotizing infection, not SSc hallmark |
| B) Large smooth pleural effusions causing passive atelectasis | ✗ Incorrect | • Non-specific; not characteristic |
| C) Bulky calcified mediastinal lymphadenopathy | ✗ Incorrect | • More typical of prior granulomatous disease |
| D) Patulous, fluid-filled esophagus | ✓ Correct | • SSc dysmotility predisposes to reflux/aspiration • Worsens ILD and basal ground glass • SENSCIS ancillary analyses; Distler, N Engl J Med 2019 |
7. Memory Page
Traction Forces in the
Lower Lung Fields

1
Along the Right Boronchovascular Bundle
2
Along the Right Boronchovascular Bundle
3
No Honeycombing
4
Subpleural Sparing
5
GGO

This abstract, art-inspired memory image, created with AI-assisted and Davidoff Art techniques, utilizes the letter “N” of NSIP (Nonspecific Interstitial Pneumonia) as a powerful mnemonic to illustrate key radiological features and necessary diagnostic distinctions. The first two, elongated limbs of the stylized N are positioned over the central bronchovascular bundles of the lung bases (right and left), signifying the typical peribronchovascular and subpleural distribution of the disease.
The final limb of the N, initially points toward a honeycomb pattern, which is then blocked by a universal ‘No’ sign. This is a high-yield reminder that extensive honeycombing is specifically excluded from the NSIP pattern. This rejected limb then arcs back with double-headed arrows pointing to the correct CT findings in the lower lung fields: subpleural sparing and ground-glass opacities (GGO). This artistic element strongly reinforces the features that differentiate NSIP from the Usual Interstitial Pneumonia (UIP) pattern, which typically shows definite honeycombing and lacks subpleural sparing.
The primary diagnostic utility of this mnemonic is to rapidly recall the CT pattern of NSIP: a predominantly basilar, disease distributed along the bronchovascular bundle with subpleural sparing, GGO and/or reticulation, while, crucially, distinguishing it by the absence of definite honeycombing.
Ashley Davidoff MD, AI-assisted — Memory Image – TheCommonVein.com (139946.MAD.1k)




